SHZ · 300246.SZ
Guangdong Biolight Meditech Co., Ltd.
CN¥12.02-CN¥0.25 (-2.04%)
Guangdong Biolight Meditech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 45.31% below the high.
Loading market information…
SHZ · 300030.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:04 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Improve Medical Instruments Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.78% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Improve Medical Instruments Co., Ltd.’s forward annual dividend is CN¥0.04 per share, paid annual. The forward yield is 0.55% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Improve Medical Instruments Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Improve Medical Instruments Co., Ltd. operates as an international supplier, delivering advanced technologies, medical products, and critical services to clinical laboratories and for patient care, spanning both the Chinese market and global regions. A significant portion of its product portfolio comprises leading brands such as IMPROVACUTER evacuated blood collection systems, IMPROMINI capillary blood collection systems, IMPROSWAB microbiological transport systems, IMPRONURSE infusion and syringe pumps, and LONGX urine analysis platforms, alongside an assortment of in-vitro diagnostic reagents. Furthermore, the company's comprehensive offerings extend to a wide range of ancillary equipment and disposables, including blood collection needles, pulsewave blood pressure monitors, thrombosis viscoelastic analysis systems, feces analysis systems, automated blood and urine collection tube preparation systems, graphical user interface (GUI) devices, intelligent sorting units, multi-functional blood collection workstations, smart queue management systems, automatic tube packing systems, and consumable labels. Originally incorporated in 1996 as Guangzhou Improve Medical Instruments Co., Ltd., the enterprise maintains its headquarters in Guangzhou, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:34 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥12.02-CN¥0.25 (-2.04%)
Guangdong Biolight Meditech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 45.31% below the high.
CN¥3.08-CN¥0.11 (-3.45%)
Jiangsu Sihuan Bioengineering Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 32.16% below the high.
CN¥22.64-CN¥0.48 (-2.08%)
Guangzhou Jet Bio-Filtration Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 25.96% below the high.
CN¥23.96-CN¥0.88 (-3.54%)
Hubei Goto Biopharm Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.46% below the high.
CN¥7.70-CN¥0.16 (-2.04%)
Jiangsu Nanfang Medical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.89% below the high.
CN¥3.53-CN¥0.23 (-6.12%)
Chengdu Huasun Technology Group Inc., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 31.46% below the high.
CN¥5.56-CN¥0.19 (-3.3%)
Hubei Guangji Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 46.64% below the high.
CN¥17.57-CN¥1.00 (-5.39%)
Guangzhou LBP Medicine Science & Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 54.9% below the high.
